Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thomas Edward Gribbin"'
Autor:
Michael J. Anderson, Marie Lee, Ronald V. Dorn, Richard C. Frank, Michael Yu, Alexander Starodub, Fa-Chyi Lee, Judith M. Joyce, Neeta Pandit-Taskar, Bert H. O'Neil, Michael L. Miller, Daniel D. Von Hoff, Michael Holt, Allyson J. Ocean, Susan Passalaqua, David M. Goldenberg, Maeve A. Lowery, Timothy C. Manzone, Wegener A. William, Fadi Braiteh, Steven J. Cohen, Michael J. Guarino, Vincent J. Picozzi, Tomislav Dragovich, Nathan Bahary, Stanley J. Goldsmith, Edward B. Strauss, Donald A. Richards, Paul Conkling, Ronald L. Korn, Ramesh K. Ramanathan, Charles M. Intenzo, Thomas Edward Gribbin, Edith P. Mitchell, Benjamin B. Bridges, Eileen M. O'Reilly, Arif Sheikh
Publikováno v:
Cancer Research. 75:B98-B98
Background: Prior clinical studies in the first and second line setting showed radioimmunotherapy (RAIT) is a promising therapy for pancreatic cancer that avoids the side effects of further chemotherapy. This multicenter study evaluated the contribut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fec2ffbe92a29021659d930511409b4d
https://doi.org/10.1158/1538-7445.panca2014-b98
https://doi.org/10.1158/1538-7445.panca2014-b98
Autor:
Donald A. Richards, Paul Conkling, William A. Wegener, Richard C. Frank, Bert H. O'Neil, Fa-Chyi Lee, Steven J. Cohen, Michael J. Guarino, Ramesh K. Ramanathan, Vincent J. Picozzi, Maeve A. Lowery, Tomislav Dragovich, Nathan Bahary, Allyson J. Ocean, David M. Goldenberg, Alexander Starodub, Thomas Edward Gribbin, Benjamin B. Bridges, Edith P. Mitchell, Fadi Braiteh
Publikováno v:
Journal of Clinical Oncology. 32:4026-4026
4026 Background: Radioimmunotherapy (RAIT) is an option to avoid side effects of further chemotherapy for advanced metastatic pancreatic ductal cancer (mPC). This multicenter, phase Ib study aimed ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3597900184c759d3092b82cc24263916
https://doi.org/10.1200/jco.2014.32.15_suppl.4026
https://doi.org/10.1200/jco.2014.32.15_suppl.4026
Autor:
Michael A. Thompson, Thomas Edward Gribbin, Maria Gonzalez, Donna M. Bryant, Ronald S. Go, Jodi L. Harr, Kimberly A. Csapo, Christie Ellison, Howard Zaren, Suresh G. Nair Md, Andrea Denicoff, Rebecca A. Enos, John Charles Leighton, Jennifer C. Corpening, Keith S. Lanier, Angela Carrigan, Eileen Dimond, Jinxiu Zhao, Kathy Wilkinson, Deborah L. Fleming
Publikováno v:
Journal of Clinical Oncology. 30:e16561-e16561
e16561 Background: The NCCCP is a network of 30 community cancer center (CCC) sites that strive to expand cancer research capacity and deliver advanced care in the community. The EPWG was formed to facilitate NCCCP site participation in EP (phase I-I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06ab294c9f98e2067ea2dc76fdb69aaf
https://doi.org/10.1200/jco.2012.30.15_suppl.e16561
https://doi.org/10.1200/jco.2012.30.15_suppl.e16561
Autor:
Maeve A. Lowery, Eileen M. O'Reilly, Donald A. Richards, Tomislav Dragovich, Paul Conkling, Arif Sheikh, Charles M. Intenzo, Heather Horne, Bert H. O'Neil, Marie Lee, Nathan Bahary, Daniel D. Von Hoff, Benjamin B. Bridges, Thomas Edward Gribbin, Alexander Starodub, Edith P. Mitchel, Allyson J. Ocean, Ronald L. Korn, Ramesh K. Ramanathan, David M. Goldenberg, Stanley J. Goldsmith, Fa-Chyi Lee, Neeta Pandit-Taskar, Fadi Braiteh, William A. Wegener, Timothy C. Manzone, Richard C. Frank, Robert M. Sharkey, Steven J. Cohen, Michael J. Guarino, Vincent J. Picozzi
Publikováno v:
European Journal of Cancer. (14):1857-1864
Background For patients with metastatic pancreatic adenocarcinoma, there are no approved or established treatments beyond the 2nd line. A Phase Ib study of fractionated radioimmunotherapy was undertaken in this setting, administering 90Y-clivatuzumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26bffbc72b2747496b954af79a594208